HDL cholesterol and apolipoprotein A-I concentrations and risk of atherosclerotic cardiovascular disease: Human genetics to unravel causality

Atherosclerosis. 2020 Apr:299:53-55. doi: 10.1016/j.atherosclerosis.2020.03.005. Epub 2020 Mar 9.

Author

Ruth Frikke-Schmidt¹

Affiliation

¹ Department of Clinical Biochemistry, Rigshospitalet and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address: ruth.frikke-schmidt@regionh.dk.

PMID: 32178836
DOI: 10.1016/j.atherosclerosis.2020.03.005

No abstract available

Keywords: Apolipoprotein A-I; HDL cholesterol; Human genetics; Mendelian randomization studies; Randomized clinical trials.

Publication types

Editorial
Comment

MeSH terms

Apolipoprotein A-I
Cardiovascular Diseases*
Cholesterol, HDL
Coronary Artery Disease*
Human Genetics*
Humans
Mendelian Randomization Analysis

Substances

Apolipoprotein A-I
Cholesterol, HDL